{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:34:32Z","timestamp":1777624472564,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44663-6","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:18:07Z","timestamp":1773692287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence, severity and associated risk factors of symptomatic dry eye among breast cancer patients receiving systemic therapy in Palestine"],"prefix":"10.1038","volume":"16","author":[{"given":"Zaina","family":"Al Nuaimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadin","family":"Abualrub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du\u2019aa","family":"Abu Amr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dania","family":"Abuhalima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husam","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samah W.","family":"Al-Jabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u2019ed H.","family":"Zyoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"44663_CR1","doi-asserted-by":"publisher","first-page":"20211033","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson, L. & Gathani, T. Understanding breast cancer as a global health concern. Br. J. Radiol. 95, 20211033. https:\/\/doi.org\/10.1259\/bjr.20211033 (2022).","journal-title":"Br. J. Radiol."},{"key":"44663_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jncc.2025.02.002","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J. Natl. Cancer Cent. 5, 287\u2013296. https:\/\/doi.org\/10.1016\/j.jncc.2025.02.002 (2025).","journal-title":"J. Natl. Cancer Cent."},{"key":"44663_CR3","doi-asserted-by":"publisher","first-page":"e70052","DOI":"10.1111\/1759-7714.70052","volume":"16","author":"T Deng","year":"2025","unstructured":"Deng, T. et al. Global, Regional, and National Burden of Breast Cancer, 1990\u20132021, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021. Thorac. Cancer. 16, e70052. https:\/\/doi.org\/10.1111\/1759-7714.70052 (2025).","journal-title":"Thorac. Cancer"},{"key":"44663_CR4","unstructured":"Ithy Comprehensive Overview of 2024 Worldwide Breast Cancer Statistics, < (2025). https:\/\/ithy.com\/article\/2024-breast-cancer-statistics-worldwide-1javt4gc"},{"key":"44663_CR5","unstructured":"Ministry of Health. P. Palestinian Cancer Registry: Annual Report 2024, < (2024). https:\/\/site.moh.ps\/Content\/Books\/JsOcOwZxWZU7SAEraJ6SFLhq2Udwv2qmunFGMam4YzqmQlNtdzdsDv_XdvvM4qXsgWQDF1MjLKh8TLosrZ2ENPebOot4bCKj68sItYbuKzBhX.pdf&gt"},{"key":"44663_CR6","doi-asserted-by":"publisher","unstructured":"Smolarz, B., Nowak, A. Z. & Romanowicz, H. Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14102569 (2022).","DOI":"10.3390\/cancers14102569"},{"key":"44663_CR7","doi-asserted-by":"publisher","first-page":"e36905","DOI":"10.1097\/MD.0000000000036905","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu, E. I. & Obeagu, G. U. Breast cancer: A review of risk factors and diagnosis. Med. (Baltim). 103, e36905. https:\/\/doi.org\/10.1097\/MD.0000000000036905 (2024).","journal-title":"Med. (Baltim)."},{"key":"44663_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","volume":"5","author":"Y Feng","year":"2018","unstructured":"Feng, Y. et al. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 5, 77\u2013106. https:\/\/doi.org\/10.1016\/j.gendis.2018.05.001 (2018).","journal-title":"Genes Dis."},{"key":"44663_CR9","doi-asserted-by":"publisher","unstructured":"Kashyap, D. et al. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. Biomed. Res. Int. 2022 (9605439). https:\/\/doi.org\/10.1155\/2022\/9605439 (2022).","DOI":"10.1155\/2022\/9605439"},{"key":"44663_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cac2.12358","volume":"42","author":"R Hong","year":"2022","unstructured":"Hong, R. & Xu, B. Breast cancer: an up-to-date review and future perspectives. Cancer Commun. (Lond). 42, 913\u2013936. https:\/\/doi.org\/10.1002\/cac2.12358 (2022).","journal-title":"Cancer Commun. (Lond)"},{"key":"44663_CR11","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.19.01472","volume":"37","author":"K Visvanathan","year":"2019","unstructured":"Visvanathan, K. et al. Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. J. Clin. Oncol. 37, 3152\u20133165. https:\/\/doi.org\/10.1200\/JCO.19.01472 (2019).","journal-title":"J. Clin. Oncol."},{"key":"44663_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.breast.2020.07.009","volume":"53","author":"J Ma","year":"2020","unstructured":"Ma, J., Pazo, E. E., Zou, Z. & Jin, F. Prevalence of symptomatic dry eye in breast cancer patients undergoing systemic adjuvant treatment: A cross-sectional study. Breast 53, 164\u2013171. https:\/\/doi.org\/10.1016\/j.breast.2020.07.009 (2020).","journal-title":"Breast"},{"key":"44663_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3238\/arztebl.2015.0071","volume":"112","author":"EM Messmer","year":"2015","unstructured":"Messmer, E. M. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch. Arztebl Int. 112, 71\u201381. https:\/\/doi.org\/10.3238\/arztebl.2015.0071 (2015). quiz 82.","journal-title":"Dtsch. Arztebl Int."},{"key":"44663_CR14","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1167\/iovs.11-8027","volume":"52","author":"BE Dougherty","year":"2011","unstructured":"Dougherty, B. E., Nichols, J. J. & Nichols, K. K. Rasch analysis of the Ocular Surface Disease Index (OSDI). Invest. Ophthalmol. Vis. Sci. 52, 8630\u20138635. https:\/\/doi.org\/10.1167\/iovs.11-8027 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"44663_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman, R. M., Christianson, M. D., Jacobsen, G., Hirsch, J. D. & Reis, B. L. Reliability and validity of the Ocular Surface Disease Index. Arch. Ophthalmol. 118, 615\u2013621. https:\/\/doi.org\/10.1001\/archopht.118.5.615 (2000).","journal-title":"Arch. Ophthalmol."},{"key":"44663_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/ICO.0000000000000038","volume":"33","author":"JR Grubbs Jr","year":"2014","unstructured":"Grubbs, J. R. Jr., Tolleson-Rinehart, S., Huynh, K. & Davis, R. M. A review of quality of life measures in dry eye questionnaires. Cornea 33, 215\u2013218. https:\/\/doi.org\/10.1097\/ICO.0000000000000038 (2014).","journal-title":"Cornea"},{"key":"44663_CR17","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/jcm10122620","volume":"10","author":"A Grasso","year":"2021","unstructured":"Grasso, A. et al. Sex Hormones Related Ocular Dryness in Breast Cancer Women. J. Clin. Med. 10, 2620 (2021).","journal-title":"J. Clin. Med."},{"key":"44663_CR18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41433-021-01612-z","volume":"36","author":"A Agin","year":"2022","unstructured":"Agin, A. et al. The effects of systemic aromatase inhibitors on meibomian glands and corneal structure. Eye (Lond). 36, 1185\u20131193. https:\/\/doi.org\/10.1038\/s41433-021-01612-z (2022).","journal-title":"Eye (Lond)"},{"key":"44663_CR19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.breast.2015.08.008","volume":"24","author":"H Inglis","year":"2015","unstructured":"Inglis, H., Boyle, F. M., Friedlander, M. L. & Watson, S. L. Dry eyes and AIs: If you don\u2019t ask you won\u2019t find out. Breast 24, 694\u2013698. https:\/\/doi.org\/10.1016\/j.breast.2015.08.008 (2015).","journal-title":"Breast"},{"key":"44663_CR20","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s10792-020-01384-7","volume":"40","author":"T Bicer","year":"2020","unstructured":"Bicer, T. et al. The effects of adjuvant hormonotherapy on tear functions in patients with breast cancer. Int. Ophthalmol. 40, 2077\u20132083. https:\/\/doi.org\/10.1007\/s10792-020-01384-7 (2020).","journal-title":"Int. Ophthalmol."},{"key":"44663_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/08164622.2023.2239247","volume":"107","author":"G Machairoudia","year":"2024","unstructured":"Machairoudia, G. et al. Prevalence and risk factors of dry eye disease in patients treated with aromatase inhibitors for breast cancer. Clin. Exp. Optom. 107, 415\u2013419. https:\/\/doi.org\/10.1080\/08164622.2023.2239247 (2024).","journal-title":"Clin. Exp. Optom."},{"key":"44663_CR22","unstructured":"Raosoft Raosoft Sample size calculator, < (2004). http:\/\/www.raosoft.com\/samplesize.html"},{"key":"44663_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/09273940701486803","volume":"15","author":"F Ozcura","year":"2007","unstructured":"Ozcura, F., Aydin, S. & Helvaci, M. R. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol. Inflamm. 15, 389\u2013393. https:\/\/doi.org\/10.1080\/09273940701486803 (2007).","journal-title":"Ocul Immunol. Inflamm."},{"key":"44663_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jval.2011.08.1739","volume":"15","author":"SF Garcia","year":"2012","unstructured":"Garcia, S. F. et al. Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16). Value Health. 15, 183\u2013190. https:\/\/doi.org\/10.1016\/j.jval.2011.08.1739 (2012).","journal-title":"Value Health"},{"key":"44663_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12955-019-1162-5","volume":"17","author":"M Krohe","year":"2019","unstructured":"Krohe, M. et al. Content validity of the National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Breast Cancer Symptom Index (NFBSI-16) and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form with advanced breast cancer patients. Health Qual. Life Outcomes. 17, 92. https:\/\/doi.org\/10.1186\/s12955-019-1162-5 (2019).","journal-title":"Health Qual. Life Outcomes"},{"key":"44663_CR26","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.18240\/ijo.2021.10.18","volume":"14","author":"MM Bakkar","year":"2021","unstructured":"Bakkar, M. M., El-Sharif, A. K. & Al Qadire, M. Validation of the Arabic version of the Ocular Surface Disease Index Questionnaire. Int. J. Ophthalmol. 14, 1595\u20131601. https:\/\/doi.org\/10.18240\/ijo.2021.10.18 (2021).","journal-title":"Int. J. Ophthalmol."},{"key":"44663_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12886-019-1290-z","volume":"20","author":"Y Shanti","year":"2020","unstructured":"Shanti, Y., Shehada, R., Bakkar, M. M. & Qaddumi, J. Prevalence and associated risk factors of dry eye disease in 16 northern West bank towns in Palestine: a cross-sectional study. BMC Ophthalmol. 20, 26. https:\/\/doi.org\/10.1186\/s12886-019-1290-z (2020).","journal-title":"BMC Ophthalmol."},{"key":"44663_CR28","doi-asserted-by":"publisher","first-page":"101155","DOI":"10.1016\/j.esmoop.2023.101155","volume":"8","author":"L Grassi","year":"2023","unstructured":"Grassi, L. et al. Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline. ESMO Open. 8, 101155. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101155 (2023).","journal-title":"ESMO Open."},{"key":"44663_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/21642850.2020.1770093","volume":"8","author":"M Toth","year":"2020","unstructured":"Toth, M. & Jokic-Begic, N. Psychological contribution to understanding the nature of dry eye disease: a cross-sectional study of anxiety sensitivity and dry eyes. Health Psychol. Behav. Med. 8, 202\u2013219. https:\/\/doi.org\/10.1080\/21642850.2020.1770093 (2020).","journal-title":"Health Psychol. Behav. Med."},{"key":"44663_CR30","doi-asserted-by":"publisher","first-page":"e0271267","DOI":"10.1371\/journal.pone.0271267","volume":"17","author":"L Qian","year":"2022","unstructured":"Qian, L. & Wei, W. Identified risk factors for dry eye syndrome: A systematic review and meta-analysis. PLoS One. 17, e0271267. https:\/\/doi.org\/10.1371\/journal.pone.0271267 (2022).","journal-title":"PLoS One"},{"key":"44663_CR31","doi-asserted-by":"publisher","unstructured":"Al-Subaie, M., Khan, A. S. & Khan, M. T. Associated Risk Factors with the Presence of the Symptoms of Dry Eye Syndrome among Residents of Al Ahsa, Saudi Arabia. Al-Basar Int. J. Ophthalmol. 6, 6\u20139. https:\/\/doi.org\/10.4103\/bijo.bijo_1_19 (2019).","DOI":"10.4103\/bijo.bijo_1_19"},{"key":"44663_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/jcm14010196","volume":"14","author":"E Villani","year":"2025","unstructured":"Villani, E. et al. From Symptoms to Satisfaction: Optimizing Patient-Centered Care in Dry Eye Disease. J. Clin. Med. 14, 196 (2025).","journal-title":"J. Clin. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44663-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44663-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44663-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:27:27Z","timestamp":1777418847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44663-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44663"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44663-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the participants, and the study and its protocols received approval from the Institutional Review Board Committee of An-Najah National University [IRB Reference #: Pharm. Sep. 2021\/12]. Necessary permission was obtained from the local authorities. We confirm that all the experiments and methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13701"}}